About Intensity Therapeutics, Inc. 
Intensity Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (1.17%)
Foreign Institutions
Held by 2 Foreign Institutions (0.05%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
USD 24 Million ()
NA (Loss Making)
NA
0.00%
-0.97
-162.50%
3.30






